A number of studies show the relation between oxygen-derived free radicals and cardiac ischemia/ reperfusion injury. However, little is known about oxidative stress in the human heart, which can be measured by oxidized glutathione (GSSG) and malondialdehyde (MDA) formation. Furthermore, data on MDA production by rat hearts are controversial, possibly because of the use of the aspecific thiobarbituric acid assay. Therefore, GSSG and MDA were measured, with colorimetric and high-performance liquid chromatographic assays, respectively, in buffer-perfused explanted human hearts and normal rat hearts made temporarily ischemic. Human hearts received cardioplegia; rat hearts were studied in a control and an ischemic group with or without cardioplegia. Baseline GSSG release was <0.01 nmol * min'. g wet wt-1 in both species. During reperfusion, GSSG release from human hearts and from ischemic and cardioplegic/ischemic rat hearts peaked at 0.24±0.12, 1.1±0.4, and 0.19±0.04 nmol min'* g-', respectively. MDA was undetectable (<0.02 nmol* min' g-') in the effluent of both species and in human hearts (<4 nmol/g protein). Rat heart reduced glutathione levels decreased 32% as a consequence of cardioplegia and ischemia. Cardioplegia induced a 41% (P=.08) decrease in rat heart MDA content, whereas cumene hydroperoxide increased it 3.6 times (P<.01). Thus, after ischemia human and rat hearts release GSSG, indicating that oxidative stress has occurred. Apparently, lipid peroxidation takes place in normal rat hearts, decreases after cardioplegia, but does not increase after ischemia/reperfusion. Human hearts lack MDA under normoxic and ischemic conditions. This novel finding seems to reflect a low MDA-forming potential in both situations. Substantial amounts of MDA are only formed under extreme conditions, like perfusion with cumene hydroperoxide, when scavenging systems cannot cope with the amounts of free radicals formed. MDA found in clinical studies could come from an extracardiac source or could be due to the use of the aspecific thiobarbituric acid assay. (Circ Res. 1993;73:681-688 Blood was washed from the hearts for 10 minutes, and then recirculation was started with 1.0 to 1.5 L perfusion fluid. After a 30-minute control period, the hearts were subjected to 20 minutes of no-flow ischemia, followed by a 30-minute reperfusion period. Arterial and venous samples were collected at regular intervals. Biopsies (0.1 g) were taken from multiple locations of the left ventricle with a Tru-cut needle (Travenol Laboratories, Deerfield, Ill) before the onset of the preparation period and after 30 minutes of reperfusion; they were immediately frozen with liquid nitrogen.
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Maarten Janssen, Johan F. Koster, Egbert Bos, Jan Willem de Jong A number of studies show the relation between oxygen-derived free radicals and cardiac ischemia/ reperfusion injury. However, little is known about oxidative stress in the human heart, which can be measured by oxidized glutathione (GSSG) and malondialdehyde (MDA) formation. Furthermore, data on MDA production by rat hearts are controversial, possibly because of the use of the aspecific thiobarbituric acid assay. Therefore, GSSG and MDA were measured, with colorimetric and high-performance liquid chromatographic assays, respectively, in buffer-perfused explanted human hearts and normal rat hearts made temporarily ischemic. Human hearts received cardioplegia; rat hearts were studied in a control and an ischemic group with or without cardioplegia. Baseline GSSG release was <0.01 nmol * min'. g wet wt-1 in both species. During reperfusion, GSSG release from human hearts and from ischemic and cardioplegic/ischemic rat hearts peaked at 0.24±0.12, 1.1±0.4, and 0.19±0.04 nmol min'* g-', respectively. MDA was undetectable (<0.02 nmol* min' g-') in the effluent of both species and in human hearts (<4 nmol/g protein). Rat heart reduced glutathione levels decreased 32% as a consequence of cardioplegia and ischemia. Cardioplegia induced a 41% (P=.08) decrease in rat heart MDA content, whereas cumene hydroperoxide increased it 3.6 times (P<.01). Thus, after ischemia human and rat hearts release GSSG, indicating that oxidative stress has occurred. Apparently, lipid peroxidation takes place in normal rat hearts, decreases after cardioplegia, but does not increase after ischemia/reperfusion. Human hearts lack MDA under normoxic and ischemic conditions. This novel finding seems to reflect a low MDA-forming potential in both situations. Aconsiderable number of studies show that oxygen-derived free radicals can cause injury related to cardiac ischemia/reperfusion.' Various free radical sources, like the mitochondrial respiratory chain, arachidonic acid, leukocytes, and endothelial xanthine oxidoreductase, could play a role. McCord2 postulated that, during myocardial ischemia, xanthine dehydrogenase is converted to xanthine oxidase, which forms superoxide radicals upon reperfusion.
Superoxide dismutase converts superoxide to hydrogen peroxide,3 which can react with iron to form the highly cytotoxic hydroxyl radical (Haber-Weiss reaction).4-6 The latter can initiate the peroxidation of polyunsaturated fatty acids in cell membranes and thus impair or destroy cell function. Since catalase activity in myocardial tissue is very low,7 glutathione peroxidase seems to be crucial in detoxifying hydrogen peroxide via reduced glutathione (GSH). The excess of oxidized glutathione (GSSG) inside the cell is converted back to GSH by glutathione reductase or actively transported out of the cell.8
Direct detection of oxygen-derived free radicals is almost impossible because of their instability and consequent short half-life. Electron spin resonance or spin trapping provides a new direct method to measure free radical formation.9'10 Indirect probing can be done by measuring compounds associated with the detoxification, by assaying products generated, or by applying free radical scavengers.
GSSG levels in tissue and coronary effluent rise during lack of oxygen.7 8 To circumvent the possible influence of blood components, the isolated buffer-perfused heart is a useful model for investigating the effects of ischemia/reperfusion. To shed light on the MDA controversy described above, we subjected human and rat hearts to temporary ischemia and measured MDA, GSH, and GSSG in coronary effluent and tissue samples. To Blood was washed from the hearts for 10 minutes, and then recirculation was started with 1.0 to 1.5 L perfusion fluid. After a 30-minute control period, the hearts were subjected to 20 minutes of no-flow ischemia, followed by a 30-minute reperfusion period. Arterial and venous samples were collected at regular intervals. Biopsies (0.1 g) were taken from multiple locations of the left ventricle with a Tru-cut needle (Travenol Laboratories, Deerfield, Ill) before the onset of the preparation period and after 30 minutes of reperfusion; they were immediately frozen with liquid nitrogen.
In a pilot experiment, perfusion took place 30 minutes with buffer supplemented with 0.5 mmol/L cumene hydroperoxide (Merck, Amsterdam, The Netherlands) to induce lipid peroxidation.
Rat Heart Perfusions
Adult male Wistar rats (400 to 450 g) were anesthetized intraperitoneally with 60 mg/kg pentobarbital (Nembutal, Sanofi, Paris, France) in accordance with guidelines of the American Physiological Society. Hearts were removed, arrested in ice-cold saline, and retrogradely perfused with a modified Tyrode's buffer oxygenated with 95% 02-5% CO2 at 72 mm Hg and 37°C. Cannulation of the aorta was done <1 minute after arrest. Coronary flow was measured electromagnetically (Skalar, Delft, The Netherlands). Hearts were perfused in a nonrecirculating mode for 30 minutes, and then recirculation was started with a total volume of 100 mL. At this point, the hearts were divided into three groups. Control hearts (n=9) were recirculated for 60 subjected to 20 minutes of ischemia, followed by 30 minutes of reperfusion. The third group (n=6) was perfused for 30 minutes with buffer supplemented with 0.5 mmol/L cumene hydroperoxide to induce lipid peroxidation.
To check the influence of a prolonged transportation and preparation period (compare with human hearts), two additional groups (n=7) of rat hearts were investigated. Hearts were removed from the thorax as described above and immediately flushed for 3 minutes with gassed (95% 02-5% C02) ice-cold St. Thomas' Hospital cardioplegic solution. 21 The organs, submerged in the cardioplegic solution, were put on melting ice for 40 minutes. Then they were connected to the perfusion system and subjected to the protocols (cardioplegic control and cardioplegic/ischemic groups) described above.
In the groups mentioned above, samples were collected every 5 minutes. Because of the minimal arteriovenous differences, release was calculated from the increase in catabolite concentration divided by the time interval. Because of the lag time in the recirculating system, sampling was omitted during the first few minutes of reperfusion. At the end of the experiments, hearts were freezeclamped at liquid nitrogen temperature.
To investigate if GSSG release reflected production or increased washout, we subjected hearts (n=6) to 20 minutes of ischemia after a 30-minute stabilization period and perfused them for 1 minute before they were freeze-clamped.
Glutathione Determination
Effluent samples were deproteinized with 4% HC104 (final concentration), centrifuged at 10 000g for 2 minutes, and neutralized with 6 mol/L KOH and 2 mol/L K2CO3. Tissue was crushed in liquid nitrogen and deproteinized with 5% sulfosalicylic acid.24 After centrifugation at 10 000g for 2 minutes, the supernatant fluid was neutralized with 6 mol/L KOH and 2 mol/L K2CO3. Total glutathione (GSH+GSSG) and GSSG were analyzed according to Ceconi et a125 on a doublebeam spectrophotometer (model U-2000, Hitachi, Tokyo, Japan). Contents were expressed per gram protein to circumvent weight problems due to (1) cumene hydroperoxide-induced loss of tissue water and (2) edema formation in isolated human hearts. The detection limit of GSSG in perfusion fluid was 0.01 nmol min-1 * g wet wt-l.
MDA Determination
Tissue samples, crushed in liquid nitrogen, and effluent samples were deproteinized with 4% HC104 (final concentration), centrifuged at 10 000g for 2 minutes, and neutralized with 6 mol/L KOH and 2 mol/L K2C03. MDA was assayed by high-performance liquid chromatography (HPLC) according to Bull and Marnet,26 with some modifications. A ,uBondapak C18 (10-,um particle diameter, Waters-Millipore, Milford, Mass), preceded by a Supelguard LC18 guard column (5-,um particle diameter, Supelco, Bellafonte, Pa), was eluted with 20% acetonitrile (vol/vol) in 1.5 mmol/L myristyltrimethylammonium bromide and 20 mmol/L sodium phosphate buffer (pH 7.2). Detection was done at 267 nm with a forward optical scanning detector (Spectra-Physics Analytical, San Jose, Calif). Peaks were identified by minutes. In the ischemic group (n = 6), hearts were comparison of retention times and spectra (multiwave- 
Results

General
The weight of the human hearts was 480±62 g (n= 8). Because of the perfusion, the weight increased 25% (P<.05). The hearts beat spontaneously within 5 minutes after connection to the perfusion system. The preischemic and postischemic heart rate was 52+6 beats per minute; average flow was 1.0 mL * min-m g wet wt-. This relatively low coronary flow seems to be adequate, since baseline lactate production was virtually absent (data not shown). Early during reperfusion, flow did not increase. The heart perfused with cumene hydroperoxide stopped beating after 25 minutes of drug infusion.
Rat heart weight (1.48±0.07 g, n=41) was similar before and after the experiments. During the stabilization period, hearts had a rate of 254±+9 beats per minute; the postischemic rate was 12% less (P=NS). Hearts stopped beating 20 minutes after the start of cumene hydroperoxide infusion.
In rat hearts, coronary flow was initially 10.5 +0.5 mL* min-'* g-'. In the control groups, flow decreased little in the course of the experiment. In the groups subjected to transient ischemia, flow Fig 1) . Efflux decreased toward baseline after 10 minutes of reperfusion. GSSG was undetectable in the control period. After 4 minutes of reperfusion, the release amounted to 0.24±0.12 nmol* min-l . g (P<.05 vs baseline). GSSG efflux ceased after 5 minutes (Fig 1) .
Postischemic myocardial GSH content was 50% lower than the control value (P<.05, Table 1 amount found during 30 minutes of reperfusion in the effluent: Tissue GSH+GSSG content decreased 700 nmol/g wet wt, whereas the total amount released in 30 minutes was only 10 nmol/g. After the start of cumene hydroperoxide infusion, effluent GSH and GSSG release increased rapidly to 0.8 and 0.3 nmol* min-l g wet wt-1 , respectively. These values-somewhat higher than those after ischemia (compare with Fig 1) -decreased little during the remaining perfusion period. At the end of the experiment, tissue GSH and GSSG levels were 7.95 and 0.70 nmol/g protein, respectively. These levels were slightly lower than those observed after ischemia/reperfusion (compare with Table 1 ).
Glutathione in Rat Heart Effluent and Tissue
Control and cardioplegic control rat hearts released no GSH and GSSG. GSH efflux increased rapidly to 5.4±0.8 and 0.8+±0.2 nmol min-l . g wet wt-1 in the ischemic (Fig 2A) and cardioplegic/ischemic (Fig 2B) group, respectively (P<.001). In the ischemic group, GSSG efflux amounted to 1.0±+0.3 nmol* min1 . g`1 at 10 minutes of reperfusion (P<.05 versus baseline, Fig  2A) . In the cardioplegic/ischemic group, the pattern of GSSG release was similar to that in the ischemic group; however, the values were five times lower (P<.05; compare Fig 2A and 2B) .
Infusion of cumene hydroperoxide in normoxic hearts caused a biphasic release of both GSH and GSSG (Fig  3) . GSH release was of the same order of magnitude as in rat hearts made ischemic (compare with Fig 2A) . GSSG efflux was five times higher than in human and ischemic rat hearts, approximately 10 nmol* minm' g( see Figs 1 and 2A) . After 15 minutes of infusion, there was a second burst of GSH and GSSG release, coinciding with arrest of the hearts and a decrease in flow.
Tissue GSH content was 35% lower in the ischemic group than in the control group (P<.05, Table 2 ). GSSG tein, P=NS). The ratio of GSH to GSSG had decreased by a factor of 6 (P<.005).
In rat hearts, an imbalance also existed between loss of tissue glutathione and total efflux, although it was less pronounced than in human preparations. Rat heart content decreased by 400 nmol/g wet wt, whereas GSH+GSSG release in 30 minutes was 200 nmol/g.
MDA in Effluent and Tissue of Both Species
No MDA was detected in the human arterial or venous samples during the whole period of perfusion and reperfusion (detection limit, 0.02 nmol * min' g wet wt-1). In addition, we could not detect any MDA in control or ischemic/reperfused human tissue samples (detection limit, 4 nmol/g protein). MDA efflux could not be measured because of an interfering peak that coincided with MDA. This peak was not present in the effluents of the ischemic hearts and must be related to the peroxide stress. Tissue MDA amounted to 14 nmol/g protein at the end of drug infusion (n= 1).
Control and ischemic/reperfused rat hearts, with or without cardioplegia, released no detectable MDA. Cumene hydroperoxide infusion caused a rapid increase in MDA release, reaching a maximum of 13.2±+1.5 nmol minm g wet wt`after 20 minutes of perfusion (Fig 4) .
Tissue MDA content determined in rat hearts is shown in Fig 5. transported from the cell.8 Our isolated human heart data are in agreement with the clinical results of Ferrari et al. 31 Because of cardioplegia, rat hearts lost large amounts of glutathione (Table 2 ). This could explain the relatively low release from the human hearts, which were also subjected to cardioplegia. We cannot rule out the possibility that the diseased human hearts used differ in scavenging ability and behavior from normal hearts. In this respect, it is noteworthy that hypertrophied rat hearts have higher glutathione peroxidase activities. 32 In MDA as Free Radical Indicator MDA formation, assessed by the thiobarbituric acid assay, was significant in humans during pacing stress testing14 and coronary angioplasty.12,3 Both interventions disturb the cardiac oxygen supply/demand balance for short periods, ie, minutes. In view of the discrepant literature data described in the introduction, we subjected isolated hearts from humans and rats to ischemia/reperfusion. Under these conditions, MDA was undetectable (<0.02 nmol min-1 g wet wt-1) in the cardiac effluent of both species during reperfusion, regardless of the use of cardioplegia; this finding confinns the (rat heart) data of Julicher et al. 35 Under physiological conditions, MDA was present in rat myocardial tissue (41 nmol/g protein), in accordance with literature data.15 '16 The lack of MDA in human ischemic myocardial tissue could be explained in several ways. First, cardioplegia could have affected MDA content (we took our control biopsies just before ischemia). Second, the state of these diseased hearts may have interfered. We used hearts from patients undergoing transplantation for end-stage cardiac disease. Turkeys with cardiomyopathy are known to have lower lipid peroxidation.36 Nevertheless, our preliminary data indicate that cumene hydroperoxide can induce MDA formation in human heart, but the tissue value remained 10 times lower than that in rat hearts. Third. species-dependent membrane susceptibility to lipid peroxidation could explain differences between human and rat MDA tissue content. 37 Rat heart MDA content after ischemia/reperfusion in the noncardioplegic group showed a tendency to increase (Fig 5) , in agreement with the data of Ceconi et al. 15 Subjected to more drastic stress (cumene hydroperoxide), rat hearts released substantial amounts of MDA (Fig 4) , as reported in earlier work.2035 The myocardial MDA content increased significantly in comparison with p X 7XM~~~~~_ control hearts (Fig 5) . This suggests that MDA release from the heart or an increase in its myocardial content occurs only under extreme conditions like exposure to toxic hydroperoxide concentrations; then the endogenous scavenging systems apparently cannot cope with the large amounts of free radicals formed.
The absence of MDA formation in the isolated human heart preparations sheds doubt on the reports on MDA found in clinical studies. Until now, the source of free radicals was unclear. False-positive reports could be ascribed to the classic, aspecific, colorimetric thiobarbituric acid assay for MDA, which also measures other aldehydes. Effect of Cardioplegia on Glutathione and MDA Content Although cardioplegia followed by ischemia might be beneficial for postischemic functional recovery, restoration of blood flow paradoxically poses a threat to the myocardium. Concomitant with reoxygenation, superoxide radical formation, as well as washout of important cellular compounds, takes place.
We found that GSH levels decreased by a factor of 1.5 as a result of cardioplegia in control rat hearts ( The increase in human heart weights evidences edema, despite the presence of the polymer dextran in the perfusion buffer. Dextran used in rat heart perfusions did not influence glutathione or MDA levels (data not shown). We are not sure whether edema influenced GSH and GSSG release.
As already mentioned, the explanted diseased human hearts may differ from normal hearts in their MDAproducing potential or scavenging ability. However, hearts of cardiac patients undergoing coronary angioplasty or other procedures could have changed to a similar, but smaller, extent.
Conclusion
After ischemia, isolated human and rat hearts released GSSG, which indicates that oxidative stress has occurred. Lipid peroxidation (as measured by MDA formation) took place in control rat hearts, decreased nonsignificantly after cardioplegia, but did not increase after ischemia/reperfusion. Substantial amounts of MDA were formed under extreme conditions, ie, perfusion with cumene hydroperoxide. Then, scavenging systems seemed unable to cope with the amounts of free radicals formed. The novel finding that human hearts lack MDA under normoxic conditions and after ischemia possibly reflects a lower MDA-producing potential. MDA found in clinical studies could come from another source or could be due to the use of the aspecific thiobarbituric acid assay.
